I'm Mark Schuman

ABOUT ME

Mark Schuman is a named partner with the firm of Carlson Caspers. Mark’s practice encompasses contested matters in the US District Courts, state courts, and administrative agencies. He has participated in many district court trials to both the bench and jury on matters related to patents, trademarks, and other intellectual property rights. He also has participated in many Markman hearings. Mark obtained a temporary restraining order and seizure order against a Taiwanese company. He also has headed ANDA litigation over the drugs Namenda XR®, OxyContin®, Prilosec®, Protonix®, Zantac® oral solution, Axert®, and Nitro-Dur® to name just a few. Mark’s technology exposure has been broad. He has headed litigation involving electronic circuitry, mechanical devices, optics, surface roughness, chemical compositions, adhesives, software, and pharmaceuticals. His other work experiences include advising clients on licensing and providing infringement and validity opinions. He has advised clients on “design around” strategies. Mark is active in bar organizations and is the past Chair of AIPLA’s Patent Litigation Committee. He also served on AIPLA’s nomination committee. Mark also served as a law clerk to the Honorable Daniel M. Friedman at the United States Court of Appeals for the Federal Circuit.